Related Experiment Video

Updated: Apr 14, 2026

Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model
08:15

Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model

Published on: June 6, 2025

743

Reduced cholesterol is associated with the depressive-like behavior in rats through modulation of the brain 5-HT1A

Shuqin Sun1, Shuo Yang2, Yongjun Mao3

  • 1Department of Geriatric Medicine, The Affiliated Hospital of Qingdao University, 16, Jiangsu Road, Qingdao, Shandong Province, 266000, China. sunsq_ahqu@163.com.

Lipids in Health and Disease
|April 19, 2015
PubMed
Abstract

Insights

Brain cholesterol, specifically in the medial prefrontal cortex (mPFC), plays a role in depression. Supplementing cholesterol in the mPFC reversed depressive behaviors in rats, suggesting a new therapeutic avenue for depression.

Area of Science:

  • Neuroscience
  • Biochemistry
  • Pharmacology

Background:

  • Low serum cholesterol is linked to increased depression risk.
  • The role of central brain cholesterol in depression and its treatment mechanisms remain unclear.
  • Investigating brain cholesterol's impact on depression is crucial for understanding and treating the disorder.

Purpose of the Study:

  • To investigate the effect of central cholesterol levels in the medial prefrontal cortex (mPFC) on depression.
  • To explore the potential regulatory mechanism involving the 5-HT1A receptor.
  • To determine if cholesterol supplementation can alleviate depressive symptoms and its underlying mechanisms.

Main Methods:

  • Rats were subjected to chronic mild stress (CMS) for 28 days to induce depressive-like behavior.
  • Cholesterol levels in the mPFC and hippocampus were measured.
  • Cholesterol supplementation and 5-HT1A receptor antagonist (WAY100635) were used to assess treatment effects and mechanisms.

Main Results:

  • CMS reduced mPFC cholesterol and induced depressive-like behaviors.
  • Dietary cholesterol supplementation reversed CMS-induced depressive behaviors.
  • Blocking the 5-HT1A receptor in the mPFC inhibited the antidepressant effects of cholesterol.

Conclusions:

  • Cholesterol in the mPFC influences 5-HT1A receptor sensitivity in depression.
  • Cholesterol's therapeutic benefits in depression may involve modulating brain 5-HT1A receptors.
  • Targeting central cholesterol metabolism could offer novel therapeutic strategies for depression.

More Related Videos

Animal Models of Depression - Chronic Despair Model CDM05:47

Animal Models of Depression - Chronic Despair Model CDM

Published on: September 23, 2021

8.4K
An Unpredictable Chronic Mild Stress Protocol for Instigating Depressive Symptoms, Behavioral Changes and Negative Health Outcomes in Rodents06:55

An Unpredictable Chronic Mild Stress Protocol for Instigating Depressive Symptoms, Behavioral Changes and Negative Health Outcomes in Rodents

Published on: December 2, 2015

23.7K

Related Concept Videos

G-protein Coupled Receptors01:21

G-protein Coupled Receptors

G-protein coupled receptors are ligand binding receptors that indirectly affect changes in the cell. The actual receptor is a single polypeptide that transverses the cell membrane seven times creating intracellular and extracellular loops. The extracellular loops create a ligand specific pocket which binds to neurotransmitters or hormones. The intracellular loops holds onto the G-protein.
134.7K
Antidepressant Drugs: MAOIs and Other Agents01:23

Antidepressant Drugs: MAOIs and Other Agents

Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
1.3K
Depression: Overview01:18

Depression: Overview

Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
1.2K
Depressive Disorders: Etiology01:27

Depressive Disorders: Etiology

Depressive disorders result from a complex interplay of biological, psychological, and sociocultural factors, each contributing uniquely to the development and persistence of the condition. Understanding these factors provides critical insight into the multifaceted nature of depression.
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
878
Antidepressant Drugs: Overview01:25

Antidepressant Drugs: Overview

Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
2.1K